Genopole
NEWSLETTER
April, 2016
Partager Partager Partager Partager
Genopole
 
VISIT THE GENOPOLE BIOCLUSTER IN 3D

This month, Genopole is launching a video presenting its campuses in 3D. View it below

3D Video

 
WHAT'S NEW AT GENOPOLE
IAR

New opportunities in San Francisco


In San Francisco, from 13th to 15th April, the IAR (Industry Agro-Resource) competitiveness cluster, in partnership with Genopole and TWB (Toulouse White Biotech) organized an exploratory mission entitled “Biologie de synthèse et biotechnologies industrielles” (Synthetic biology and industrial biotechnologies). This was the opportunity for Genopole to meet with great organizations.

 
Read more {...} read more
 
NEWS FROM THE BIOCLUSTER COMPANIES

Welcome!


Genopole is proud to introduce Acticor Biotech, a spin-off from the Inserm (French National Institute of Health and Medical Research) dedicated to the development of an innovative therapeutic strategy for a safe and effective emergency treatment of ischemic strokes.

Acticor
Acticor Biotech develops a drug candidate, ACT-017, targeting the platelet glycoprotein VI (GPVI). This biodrug will aim at reducing death, disabilities and recurrence of ischemic stroke. The Parisian biotech is currently carrying out its second raising of funds on the crowdfunding platform Axanago.
A third of the 1.5 M euro target has already been raised. The funds will be used to finalize animal pharmacology, pursue pharmaceutical development with the Catalent GPEx® cell - having announced its alliance with Catalent in the United States in March for the development of ACT-017 - and initiate regulatory toxicology for Phase I.
The group has planned to launch a new fundraising early 2017.
The story is far from over!
Read more {...} read more
 
EVENTS

French Tax Credits


On April 12, government specialists on the French tax credits for R&D and innovation came to Genopole to explain to our entrepreneurs how to apply to both tax credits.

The R&D tax credit was created in 2002 and has since then become essential to any company doing R&D in France. In 2013, it represented more than 5 billion euros given back to companies out of the 21 billion they spent on R&D.
This R&D tax credit is for all types of industry as well as any company size. What makes the French tax credit quite unique is that it covers 30% of R&D expenditures including staff salaries and operating costs.

All the entrepreneurs found the information useful and some even requested an individual meeting with the specialists to further discuss their company's needs.


 
Read more {...} read more
 
SCIENTIFIC NEWS


Super-resolution microscopy at Genopole

Research carried out at Genopole requires photonic fluorescence microscopy for cell analysis. With this in mind, Genopole recently acquired two nanoscopes - or super-resolution microscopes - that will enable researchers to extend their exploration field and to study biological mechanisms at higher optical resolution than that of traditional microscopy.
Super resolution microscopy
As such, the Leica TCS SP8 STED 3X confocal nanoscope and high-resolution Zeiss LSM880-AiryScan confocal spectral microscope will enable scientists to observe living cells much faster and at a better resolution, and to study many biological mechanisms at a molecular scale.
 
NETWORKING  

UEVE HUST


Genopole in Wuhan and Shanghai


Genopole was represented at the signature of a new partnership agreement between Université d'Évry-Val-d'Essonne (UEVE) and Huazhong University of Science and Technology (HUST), on April 8, in Wuhan (China).
UEVE and HUST are creating a joint Masters program in Molecular Biology with special emphasis on bioinformatics, cell and gene therapy.

The Chinese and French students entering the program will share their time between HUST and UEVE.
The delegation from UEVE and Genopole also visited Wuhan's BioLake biotech park to discuss the extension of the exchange agreement already established between Genopole and BioLake since 2011.
As part of this mission of Genopole in China, meetings were also held with Juke Biotech Park, NewSummit BioPharma and Zhangjiang Hi-Tech Park representatives in Shanghai.
Topics of common interest include reciprocal soft landing initiatives between Chinese bioclusters and Genopole, current developments in personalized medicine, as well as R&D in cell and gene therapy, and in synthetic biology.

 
VISITS


Russian Delegation at Genopole

Genopole hosted the Russian Vice-Minister of the Ministry of Education and Research (Minobrauk), Dr. Ludmilla Ogorodova, as well as Dr. Michael Igrumov, member of the Presidium of Russian Academy of Sciences, who are both involved in Russia's task force that drives reforms in R&D and innovation and that aims at making more space in the national research initiatives for life sciences.

Ynsect
The Director of Russia's International Center for Innovation in Science, Technology and Education, Ms Irina Kuklina, was also part of the Russian delegation to Genopole. Minobrauk currently leads a number of projects to enhance Russia's research and innovation efforts - including the establishment of R&D infrastructure and bioclusters - and has identified Genopole as a benchmark for a case study.
Russia and France are celebrating this year the 50th anniversary of the first bilateral scientific and technological cooperation agreement between the two countries, and priority collaborative areas for the future include (amongst others) new developments in biotechnologies, health sciences, novel materials and nanotechnologies.
 
  AND ALSO...  


Biomathematics Conference


You can now view the Webcasts from the Biomathematics Conference that was held in November here.
 

Bio


BIO 2016 - San Francisco


Partnering is now open for BIO 2016 at San Francisco. Be sure to connect with us there!
Read more (...)

 

 
  For additional information, write to international@genopole.fr